| Revenue | {{ Info.Revenue | formatUSD }} |
| Headquarters | {{ Info.Headquarters }} |
| As of Date | 03/31/2025 |
| Adviser Type - Large advisory firm | |
| Number of Employees | 6 -25% |
| of those in investment advisory functions | 3 -25% |
| Registration | SEC, Approved, 07/30/2021 |
|
|
|
| AUM* | 167,923,113 14% |
| of that, discretionary | 167,923,113 14% |
| Private Fund GAV* | 167,923,113 -26% |
| Avg Account Size | 55,974,371 14% |
| SMA’s | No |
| Private Funds | 3 |
| Contact Info | 646 xxxxxxx |
| Websites |
- Pooled investment vehicles
- Portfolio management for pooled investment vehicles
- A percentage of assets under your management
- Performance-based fees
| Fund Type | Count | GAV |
|---|---|---|
| Fund TypeHedge Fund | Count3 | GAV$167,923,113 |
| Adviser | Hedge Fund | Liquidity Fund | Private Equity Fund | Real Estate Fund | Securitized Asset Fund | Venture Capital Fund | Other Fund | Total Private Fund GAV | AUM | #Funds | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Adviser CLOUD CAPITAL | Hedge Fund- | Liquidity Fund- | Private Equity Fund- | Real Estate Fund- | Securitized Asset Fund- | Venture Capital Fund- | Other Fund270.0k | Total Private Fund GAV270.0k | AUM189.9m | #Funds1 | |
| Adviser PENBROOK MANAGEMENT LLC | Hedge Fund7.4m | Liquidity Fund- | Private Equity Fund- | Real Estate Fund- | Securitized Asset Fund- | Venture Capital Fund- | Other Fund- | Total Private Fund GAV7.4m | AUM169.8m | #Funds1 | |
| Adviser CRAWFORD FUND MANAGEMENT, LLC | Hedge Fund65.2m | Liquidity Fund- | Private Equity Fund- | Real Estate Fund- | Securitized Asset Fund- | Venture Capital Fund- | Other Fund- | Total Private Fund GAV65.2m | AUM184.7m | #Funds1 | |
| Adviser COVEY CAPITAL ADVISORS, LLC | Hedge Fund- | Liquidity Fund- | Private Equity Fund- | Real Estate Fund- | Securitized Asset Fund- | Venture Capital Fund- | Other Fund- | Total Private Fund GAV- | AUM152.8m | #Funds- | |
| Adviser DAVENTRY GROUP LP | Hedge Fund271.3m | Liquidity Fund- | Private Equity Fund- | Real Estate Fund- | Securitized Asset Fund- | Venture Capital Fund- | Other Fund- | Total Private Fund GAV271.3m | AUM313.0m | #Funds3 | |
| Adviser SIERRA GLOBAL MANAGEMENT, LLC | Hedge Fund- | Liquidity Fund- | Private Equity Fund- | Real Estate Fund- | Securitized Asset Fund- | Venture Capital Fund- | Other Fund- | Total Private Fund GAV- | AUM145.4m | #Funds- | |
| Adviser KANAME CAPITAL, L.P. | Hedge Fund185.0m | Liquidity Fund- | Private Equity Fund- | Real Estate Fund- | Securitized Asset Fund- | Venture Capital Fund- | Other Fund- | Total Private Fund GAV185.0m | AUM201.7m | #Funds1 | |
| Adviser METAURUS ADVISORS LLC | Hedge Fund7.4m | Liquidity Fund- | Private Equity Fund- | Real Estate Fund- | Securitized Asset Fund- | Venture Capital Fund- | Other Fund- | Total Private Fund GAV7.4m | AUM953.7m | #Funds1 | |
| Adviser HIDDENITE CAPITAL PARTNERS LP | Hedge Fund135.4m | Liquidity Fund- | Private Equity Fund- | Real Estate Fund- | Securitized Asset Fund- | Venture Capital Fund- | Other Fund- | Total Private Fund GAV135.4m | AUM137.8m | #Funds3 | |
| Adviser ORACLE ALPHA INC | Hedge Fund- | Liquidity Fund- | Private Equity Fund- | Real Estate Fund- | Securitized Asset Fund- | Venture Capital Fund- | Other Fund- | Total Private Fund GAV- | AUM172.9m | #Funds- |
| Stock Ticker | Stock Name | $ Position | % Position | $ Change | # Change |
|---|---|---|---|---|---|
| Stck Ticker834203309 | Stock NameSOLENO THERAPEUTICS INC | $ Position$20,447,851 | % Position12.00% | $ Change36.00% | # Change69.00% |
| Stck Ticker834203309 | Stock NameSOLENO THERAPEUTICS INC (CALL) | $ Position$16,900,000 | % Position10.00% | $ Change | # Change |
| Stck Ticker558868105 | Stock NameMADRIGAL PHARMACEUTICALS INC | $ Position$14,980,753 | % Position9.00% | $ Change | # Change |
| Stck TickerN0731H103 | Stock NameATAI BECKLEY NV | $ Position$12,098,256 | % Position7.00% | $ Change | # Change |
| Stck Ticker04351P101 | Stock NameASCENDIS PHARMA A/S - ADR | $ Position$10,155,215 | % Position6.00% | $ Change | # Change |
| Stck Ticker52635N103 | Stock NameLENZ THERAPEUTICS INC | $ Position$8,168,409 | % Position5.00% | $ Change-19.00% | # Change-49.00% |
| Stck Ticker76029N106 | Stock NameREPLIMUNE GROUP INC (CALL) | $ Position$7,751,500 | % Position5.00% | $ Change | # Change |
| Stck Ticker877619106 | Stock NameTAYSHA GENE THERAPIES INC | $ Position$6,206,826 | % Position4.00% | $ Change | # Change |
| Stck Ticker76029N106 | Stock NameREPLIMUNE GROUP INC (CALL) | $ Position$7,332,500 | % Position4.00% | $ Change | # Change |
| Stck Ticker20451W101 | Stock NameCOMPASS PATHWAYS PLC | $ Position$5,881,169 | % Position4.00% | $ Change41.00% | # Change-31.00% |